ADMA BIOLOGICS, INC. — Director's Dealing 2012

Apr 7, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ADMA BIOLOGICS, INC. (NONE)
CIK: 0001368514
Period of Report: 2012-04-04

Reporting Person: RICHMAN ERIC I (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-04-04	Options to purchase	$9.60	A	26517	Acquired	2022-04-04	Common Stock (26517)	Direct

Footnotes

F1: These options vest over four years with 25% vesting on April 4, 2013, the first anniversary of the date of grant, and the remaining 75% vesting pro rata over the next 36 months.